An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

Autor:	Nile, Donna L.1 Donna.Nile@glasgow.ac.uk, Rae, Colin1, Hyndman, Iain J.1, Gaze, Mark N.2, Mairs, Robert J.1
Zdroj:	BMC Cancer. 8/11/2016, Vol. 16, p1-13. 13p. 7 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu